Events

NABR Webinar: Q&A With the USDA - The 12th Edition NABR is once again pleased to announce the return of one of its most requested webinars,  "Q&A with the USDA." Join […]

Introduction to FDA’s Office of Trade and Global Partnerships July 23, 2024 – Webinar Introduction to FDA’s Office of Trade and Global Partnerships Learn about the FDA’s Office of Trade […]

Environmental Monitoring in Compounding July 30, 2024 – Webinar Environmental Monitoring in Compounding Get an overview of environmental monitoring for compounding facilities and the role it plays in ensuring product […]

Next National Advisory Council on Drug Abuse Meeting: September 11 The National Advisory Council on Drug Abuse (NACDA) serves a crucial role in advising NIDA, and, by extension, the Director, […]

Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 September 12, 2024 ­– Webinar 8:45 am-5:45pm Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 This […]

Sex Differences in Addiction Workshop  Organized in conjunction with ACU’s Healthy Brain and Mind Research Centre, experts from the National Institute on Drug Abuse, and the ENIGMA consortium When: Friday 27 […]

NABR Webinar: “Current and Future Challenges Facing Biomedical Research” Please join us on Tuesday, Oct. 8, at 12:30 p.m. EST for the 61st NABR webinar when Matt Bailey, President of […]

Professional NIH Grant Development Live Online Workshop October 15-16, 2024 10:30 a.m. to 6:00 p.m. Eastern Time Sponsored by the Grant Training Center The Professional NIH Grant Development live online […]

FDA and NIH Joint Public Meeting on Advancing Smoking Cessation Priorities REGISTRATION IS OPEN On Monday, October 21, from 9 a.m. to 4:30 p.m. EDT, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will host a joint public meeting entitled, “Advancing Smoking Cessation: FDA and NIH Priorities.” The focus […]

Advancing Smoking Cessation: FDA and NIH Priorities Attend the joint public meeting hosted by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). Goals and Objectives:  This public meeting will address the need for novel smoking cessation products to help individuals of all ages, including underserved and vulnerable populations, stop smoking. […]

Join January 16 FDA Grand Rounds - The PATH from Data to Action: Key Findings from the Population Assessment of Tobacco and Health Study to Inform FDA’s Regulatory Activities The Population Assessment of Tobacco and Health (PATH) Study, a national, longitudinal cohort study of tobacco use and health in the United States, is one of […]